Dual orexin receptor antagonist (DORA) for insomnia

Belsomra (suvorexant) Withdrawal

Belsomra (suvorexant) works by blocking orexin (a wake-promoting signal) rather than enhancing GABA like benzodiazepines and Z-drugs. It was designed to avoid the dependence and rebound seen with older hypnotics, and in studies it shows little physical withdrawal. The most common effect of stopping is mild, transient rebound insomnia.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

~12 hours. Suvorexant is a newer class of sleep medication (FDA-approved 2014); dedicated discontinuation data are more limited than for older hypnotics.

Withdrawal timeline

Onset— Night 1-2 after stopping

Some return of difficulty sleeping is the usual first and main effect.

Peak— First few nights

Mild rebound insomnia, if it occurs, is most noticeable in the first nights and is generally less pronounced than with Z-drugs.

Resolution— Several nights to ~1 week

Sleep typically re-stabilizes within a week; significant physical withdrawal is not expected.

Common symptoms

  • Mild rebound insomnia
  • Restless or lighter sleep for a few nights

Less common

  • Daytime fatigue
  • Mild anxiety about sleep

Tapering guidance

  • A strict taper is usually not required given the low dependence potential, but stepping down after nightly long-term use can ease rebound insomnia.
  • Coordinate with the prescribing physician if insomnia is part of a broader mood or anxiety picture.

Where ketamine therapy fits

Ketamine therapy does not treat suvorexant discontinuation. It can be relevant when insomnia is a symptom of an underlying depression or anxiety rather than a primary sleep problem - treating the mood disorder often improves the sleep. Coordinate with the prescribing physician.

Check ketamine therapy eligibilityMedication safety with ketamine

Frequently asked questions

Does Belsomra cause withdrawal?

It was designed to avoid the dependence seen with older sleep drugs, and studies show little physical withdrawal. The main effect of stopping is mild, transient rebound insomnia.

Do I need to taper Belsomra?

Usually not, given the low dependence potential, though a step-down after long-term nightly use can ease rebound insomnia.

Can ketamine therapy help if insomnia returns?

When insomnia is driven by an underlying depression or anxiety, treating the mood disorder often improves sleep. Coordinate with your prescriber to identify the real driver.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.